From Tradition to Evidence: Exploring the Neurochemical Basis and Clinical Efficacy of Medicinal Plants in Anxiety Therapy
International Journal of Drug Delivery Technology · 11.06.2026 · 16 (48s)
DOI: 10.25258/ijddt.16.48s.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.06.2026. Verfasst von Rajdeep Kaur und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Increase in panic disorders has created an increased research interest into herbal alternatives because of people's preference toward natural therapies as well as the negative side effect profile of traditional medications (e.g., benzodiazepines). The purpose of this article is to review and summarize the current scientific literature regarding the anxiolytic effects of several medicinal plants (e.g., Piper methysticum, Valeriana officinalis, Melissa officinalis, Withania somnifera, Passiflora incarnata). A phytochemical analysis of each of these plants indicates that their therapeutic potential is due to a variety of neuropharmacological mechanisms working together. The primary mechanisms of action for each of these plants includes the modulation of the gamma-aminobutyric acid (GABA) system through GABA_A receptor agonism and the inhibition of GABA transaminase. Additionally, each plant has unique interactions with the serotonergic and dopaminergic systems. In addition to their effects on neurotransmitter systems, newly emerging data shows that these plants also have antioxidant, anti-inflammatory, and neuroprotective properties, which may help to promote neuronal resilience in the face of chronic stress. Although there are clinical trials and preclinical studies demonstrating the efficacy and safety of these types of botanical agents, there remain significant challenges related to standardization, quality assurance/quality control, and possible interactions with conventional pharmacological agents. Kava has a significant risk of causing hepatotoxicity and St. John's Wort can induce hepatic enzyme activity; thus, clinicians must strictly monitor patients with respect to liver function while on these botanical agents.All in all, to integrate evidence-based phytotherapy into traditional psychiatric practice will require further large-scale, randomized controlled human trials, as well as an advanced analytical approach (i.e. metabolomic profiling) to confirm the reproducibility and safety of standardized herbal products.
Zitieren
APA
Kaur, R., Gupta, J., & Sharma, A. (2026). From Tradition to Evidence: Exploring the Neurochemical Basis and Clinical Efficacy of Medicinal Plants in Anxiety Therapy. International Journal of Drug Delivery Technology, 16(48s). https://doi.org/10.25258/ijddt.16.48s.122
Vancouver
Kaur R, Gupta J, Sharma A. From Tradition to Evidence: Exploring the Neurochemical Basis and Clinical Efficacy of Medicinal Plants in Anxiety Therapy. International Journal of Drug Delivery Technology. 2026;16(48s). doi:10.25258/ijddt.16.48s.122
BibTeX
@article{Kaur2026,
author = {Kaur, Rajdeep and Gupta, Jyoti and Sharma, Anjali},
title = {From Tradition to Evidence: Exploring the Neurochemical Basis and Clinical Efficacy of Medicinal Plants in Anxiety Therapy},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {48s},
doi = {10.25258/ijddt.16.48s.122}
}
EUVIMED